How is RoxyBond formulated to be abuse deterrent?

RoxyBond (oxycodone hydrochloride) is formulated with SentryBond™ technology to a create a physical and chemical barrier to prevent abuse.

What is RoxyBond?

RoxyBond is an opioid agonist indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.

RoxyBond is formulated as immediate-release tablets. It is a Schedule II controlled substance with a high potential for abuse and and dependence.

How is RoxyBond Abuse-Deterrent?

RoxyBond tablets are designed to be difficult to manipulate for the purpose of misuse and abuse.

RoxyBond has increased resistance to cutting, crushing, grinding, or breaking compared to other oxycodone immediate-release tablet formulations.

RoxyBond on contact with liquid forms a viscous material that resists passage through a needle making intravenous injection difficult.

RoxyBond has physicochemical properties that are intended to reduce abuse by the intranasal route.

While RoxyBond is designed to be abuse-deterrent, abuse by intranasal, oral, and intravenous routes are still possible.